Back to All Events

Trial by Data: Efficacy and Safety Across Today’s Pharmacologic Presbyopia Drops

 
 

Presbyopia is a condition that affects nearly everyone over the age of 45. Traditional treatment options like eyeglasses and contact lenses are not ideal options for all patients. Recently pharmacologic options have come to the market. This lecture will review and update the pharmacologic treatment options for presbyopia.

Speakers: Dr. Nathan Lighthizer and Dr. Gina Wesley

Date: Wednesday, December 17, 2025

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

Thank you to Orasis Pharma for exhibiting at this event.

This event is undergoing COPE approval for 1 hour of CE credit.

Register Here
Previous
Previous
December 11

Updates in Keratoconus Research: Present and Future

Next
Next
January 28

Scleral Lens Fitting and Decision Making From Start to Finish